Field safety notices: Invivoscribe
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
2 authority publications by 2 authorities, from 28 May 2024 to 10 Jun 2024.
Latest notice: 10 Jun 2024, ANSM, MiSeq et Lymphotrack Dx IGHV Leader Somatic Hypermutation Assay Panel – MiSeq
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Invivoscribe or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
1 distinct corrective action.
Corrective action: 2 publications by AEMPS, ANSM, from 28 May 2024 to 10 Jun 2024
- MiSeq et Lymphotrack Dx IGHV Leader Somatic Hypermutation Assay Panel – MiSeq
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Master Mix TRG Miseq index 13 (Número de pieza: 22270139CE; Número de lote: 010179) incluido en el kit LymphoTrack® Dx TRG Assay Panel – MiSeqTM. Número de catálogo: 92270009
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026